 |
The Journal of Neuroscience, December 7, 2005, 25(49):11330-11339; doi:10.1523/JNEUROSCI.2313-05.2005
Previous Article | Next Article 
Neurobiology of Disease
Interaction of Cellular Prion and Stress-Inducible Protein 1 Promotes Neuritogenesis and Neuroprotection by Distinct Signaling Pathways
Marilene H. Lopes,1,2 *
Glaucia N. M. Hajj,1 *
Angelita G. Muras,1,2
Gabriel L. Mancini,1
Rosa M. P. S. Castro,1,2
Karina C. B. Ribeiro,2
Ricardo R. Brentani,1,2
Rafael Linden,3 and
Vilma R. Martins1,2
1Ludwig Institute for Cancer Research, São Paulo Branch, and 2Centro de Tratamento e PesquisaHospital do Câncer, 01509-010 São Paulo, Brazil, and 3Instituto de Biofísica da Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Cidade Universitária, 21949-900 Rio de Janeiro, Brazil
Understanding the physiological function of the cellular prion (PrPc) depends on the investigation of PrPc-interacting proteins. Stress-inducible protein 1 (STI1) is a specific PrPc ligand that promotes neuroprotection of retinal neurons through cAMP-dependent protein kinase A (PKA). Here, we examined the signaling pathways and functional consequences of the PrPc interaction with STI1 in hippocampal neurons. Both PrPc and STI1 are abundantly expressed and highly colocalized in the hippocampus in situ, indicating that they can interact in vivo. Recombinant STI1 (His6-STI1) added to hippocampal cultures interacts with PrPc at the neuronal surface and elicits neuritogenesis in wild-type neurons but not in PrPc-null cells. This effect was abolished by antibodies against either PrPc or STI1 and was dependent on the STI1 domain that binds PrPc. Binding of these proteins induced the phosphorylation/activation of the mitogen-activated protein kinase, which was essential for STI1-promoted neuritogenesis. His6-STI1, but not its counterpart lacking the PrPc binding site, prevented cell death via PKA activation. These results demonstrate that two parallel effects of the PrPcSTI1 interaction, neuritogenesis and neuroprotection, are mediated by distinct signaling pathways.
Key words: cellular prion protein; MAPK; neuritogenesis; neuroprotection; PKA; STI1
Received Feb 2, 2005;
revised October 19, 2005;
accepted October 22, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
C. Bach, S. Gilch, R. Rost, A. D. Greenwood, M. Horsch, G. N. M. Hajj, S. Brodesser, A. Facius, S. Schadler, K. Sandhoff, et al.
Prion-induced Activation of Cholesterogenic Gene Expression by Srebp2 in Neuronal Cells
J. Biol. Chem.,
November 6, 2009;
284(45):
31260 - 31269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Footz, J. L. Johnson, S. Dubois, N. Boivin, V. Raymond, and M. A. Walter
Glaucoma-associated WDR36 variants encode functional defects in a yeast model system
Hum. Mol. Genet.,
April 1, 2009;
18(7):
1276 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Caetano, M. H. Lopes, G. N. M. Hajj, C. F. Machado, C. Pinto Arantes, A. C. Magalhaes, M. D. P. B. Vieira, T. A. Americo, A. R. Massensini, S. A. Priola, et al.
Endocytosis of Prion Protein Is Required for ERK1/2 Signaling Induced by Stress-Inducible Protein 1
J. Neurosci.,
June 25, 2008;
28(26):
6691 - 6702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani
Physiology of the Prion Protein
Physiol Rev,
April 1, 2008;
88(2):
673 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Lee, L. D. Raymond, B. Schoen, G. J. Raymond, L. Kett, R. A. Moore, L. M. Johnson, L. Taubner, J. O. Speare, H. A. Onwubiko, et al.
Hemin Interactions and Alterations of the Subcellular Localization of Prion Protein
J. Biol. Chem.,
December 14, 2007;
282(50):
36525 - 36533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Wishart, J. M. Paterson, D. M. Short, S. Meredith, K. A. Robertson, C. Sutherland, M. A. Cousin, M. B. Dutia, and T. H. Gillingwater
Differential Proteomics Analysis of Synaptic Proteins Identifies Potential Cellular Targets and Protein Mediators of Synaptic Neuroprotection Conferred by the Slow Wallerian Degeneration (Wlds) Gene
Mol. Cell. Proteomics,
August 1, 2007;
6(8):
1318 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. M. Hajj, M. H. Lopes, A. F. Mercadante, S. S. Veiga, R. B. da Silveira, T. G. Santos, K. C. B. Ribeiro, M. A. Juliano, S. G. Jacchieri, S. M. Zanata, et al.
Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins
J. Cell Sci.,
June 1, 2007;
120(11):
1915 - 1926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Bredemeyer, P. E. Carrigan, T. A. Fehniger, D. F. Smith, and T. J. Ley
Hop Cleavage and Function in Granzyme B-induced Apoptosis
J. Biol. Chem.,
December 1, 2006;
281(48):
37130 - 37141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Steele, J. G. Emsley, P. H. Ozdinler, S. Lindquist, and J. D. Macklis
Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis
PNAS,
February 28, 2006;
103(9):
3416 - 3421.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|